|
Dr. Sherman has over 30 years experience in academic and pharmaceutical biomedical research. He is currently the Chairman of Angiogenix, Inc, a biopharmaceutical company developing therapeutic solutions for chronic vascular disease. Prior to Angiogenix, he served as President and CEO of Anergen Inc., a founder of Pain Therapeutics, Inc., and as Genentech's first Senior Vice President and Chief Medical Officer. He has also been a Board member and consultant to several biotechnology and pharmaceutical companies. Prior to joining Genentech in 1985, Dr. Sherman was Professor of Medicine and Endocrinology at the University of Iowa - College of Medicine where he served as Associate Chairman of the Department of Internal Medicine and Director of the NIH sponsored Clinical Research Center. Dr. Sherman is a graduate of the University of Michigan in Ann Arbor where he received both his AB and MD degrees with honors. He completed his clinical and research training at the Albert Einstein College of Medicine in New York, the National Institutes of Health in Bethesda, Maryland and at the University of Michigan. He has contributed more than 125 publications to the scientific literature including articles, chapters and books resulting from his NIH funded laboratory and human investigation and results from the study of new pharmaceuticals.
| 